Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
Preeti Gupta, Aaliya Taiyab, Afzal Hussain, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1898-1898
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
Samar Sami Alkafaas, Mohamed I. Elsalahaty, Doha F. Ismail, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 23
Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
Manzar Alam, Shoaib Alam, Anas Shamsi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 62
The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
Runze Li, Xuan-Run Wang, Jian Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 53
Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth
Deisy Segura-Villalobos, Itzel G. Ramírez-Moreno, Magnolia Martínez-Aguilar, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 349-349
Open Access | Times Cited: 42
Therapeutic implications and clinical manifestations of thymoquinone
Manzar Alam, Gulam Mustafa Hasan, Md. Meraj Ansari, et al.
Phytochemistry (2022) Vol. 200, pp. 113213-113213
Closed Access | Times Cited: 30
Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer
Masayuki Nagahashi, Yasuo Miyoshi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3354-3354
Open Access | Times Cited: 6
RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding
Ying Lin, Yun Wu, Qiangzu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Elucidating the Mechanisms of Acquired Palbociclib Resistance via Comprehensive Metabolomics Profiling
Lulu Yang, Yajun Yue, Zhendong Wang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 24-24
Open Access
Melanophilin inhibit the growth and lymph node metastasis of triple negative breast cancer via the NONO-SPHK1-S1P axis
Xing Yao, Tiffany Yuen, Qingchuan Chen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism
Lida Du, Cheng Fang, Yueqing Wang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications
Mohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 394-408
Closed Access | Times Cited: 25
Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy
Saleha Anwar, Moyad Shahwan, Gulam Mustafa Hasan, et al.
Cellular Signalling (2022) Vol. 99, pp. 110434-110434
Closed Access | Times Cited: 18
A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer
Paulina Gonzalez, Sashi Debnath, Yuan Chen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 481-481
Open Access | Times Cited: 11
Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
Revathy Nadhan, Srishti Kashyap, Ji Hee Ha, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 618-618
Open Access | Times Cited: 10
Brain region specific regulation of anandamide (down) and sphingosine-1-phosphate (up) in association with anxiety (AEA) and resilience (S1P) in a mouse model of chronic unpredictable mild stress
Caroline Fischer, Dominique Thomas, Robert Gurke, et al.
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 12, pp. 1863-1880
Open Access | Times Cited: 3
Aurora B kinase: a potential drug target for cancer therapy
Azaj Ahmed, Anas Shamsi, Taj Mohammad, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 8, pp. 2187-2198
Closed Access | Times Cited: 22
Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Cholestasis
Joy Sarkar, Hiroaki Aoki, Rongrong Wu, et al.
Annals of Surgical Oncology (2022) Vol. 30, Iss. 3, pp. 1630-1641
Open Access | Times Cited: 15
Exploring SK/S1P/S1PR pathway as a target for antiviral drug development
Sharada Prasanna Swain, Chandra Sekhara Mahanta, Madan Maurya, et al.
Health Sciences Review (2024) Vol. 11, pp. 100177-100177
Open Access | Times Cited: 2
Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway
Eileen McGowan, Yiguang Lin, Size Chen
Cancers (2022) Vol. 14, Iss. 3, pp. 535-535
Open Access | Times Cited: 13
A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P 1 signaling axis
Nick D. Bergkamp, Jeffrey R. van Senten, Hendrik J. Brink, et al.
Science Signaling (2023) Vol. 16, Iss. 798
Closed Access | Times Cited: 7
Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion
Nadia Sousa, Carsten Geiß, Laura Bîndilă, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways
Yasmin Ahmed Salama, Hanan M. Hassan, Amal M. El-Gayar, et al.
Life Sciences (2023) Vol. 337, pp. 122349-122349
Closed Access | Times Cited: 6
Ceramide-1-Phosphate Is Involved in Therapy-Induced Senescence
Alec Millner, Logan Running, Nicole Colon-Rosa, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 4, pp. 822-828
Closed Access | Times Cited: 10
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma
Yubin Kang, Pasupathi Sundaramoorthy, Cristina Gasparetto, et al.
Annals of Hematology (2022) Vol. 102, Iss. 2, pp. 369-383
Closed Access | Times Cited: 10
Elevated sphingosine-1-phosphate lyase leads to increased metabolism and reduced survival in adrenocortical carcinoma
Jack Williams, Chris Smith, Charlotte Hall, et al.
European Journal of Endocrinology (2023) Vol. 188, Iss. 1, pp. 67-77
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top